Liver AMP/ATP ratio and fructokinase expression are related to gender differences in AMPK activity and glucose intolerance in rats ingesting liquid fructose

Journal of Nutritional Biochemistry

Volumn 22, Issue 8, 2011, Pages 741-751

  Vilà, Laia ^a   Roglans, Núria ^a   Perna, Victoria ^a   Sánchez, Rosa M ^a   Vázquez Carrera, Manuel ^a   Alegret, Marta ^a   Laguna, Juan C ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Fatty acid oxidation; HNF4; IRS 2; SREBP 1

Indexed keywords

ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; FATTY ACID; FRUCTOKINASE; FRUCTOSE; GLUCOSE; HEPATOCYTE NUCLEAR FACTOR 4; INSULIN; LEPTIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRANSCRIPTION FACTOR; TRIACYLGLYCEROL;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FATTY ACID METABOLISM; FEMALE; FRUCTOSE METABOLISM; GLUCOSE INTAKE; GLUCOSE INTOLERANCE; LIVER LEVEL; MALE; METABOLIC PARAMETERS; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SEX DIFFERENCE; SIGNAL TRANSDUCTION;

ADENOSINE MONOPHOSPHATE; ADENOSINE TRIPHOSPHATE; ADIPONECTIN; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BLOOD GLUCOSE; BLOTTING, WESTERN; FEMALE; FRUCTOKINASES; FRUCTOSE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HYPERTRIGLYCERIDEMIA; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; LEPTIN; LIPID METABOLISM; LIVER; MALE; RATS; RATS, SPRAGUE-DAWLEY; SEX FACTORS; SIGNAL TRANSDUCTION; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRANSCRIPTION FACTORS; TRIGLYCERIDES;

RATTUS;

EID: 79960291596     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2010.06.005     Document Type: Article

References (41)

1. Elliott S.S., Keim N.L., Stern J.S., Teff K., Havel P.J. Fructose, weight gain, and insulin resistance syndrome. Am J Clin Nutr 2002, 76:911-922.
2. Isomaa B., Almgreen P., Tuomi T., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001, 24:683-689.
3. Cosentino F., Assenza G.E. Diabetes and inflammation. Hertz 2004, 29:749-759.
4. Rydén L., Standl E., Bartnik M., et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary, The Task force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 2007, 28:88-136.
5. Hellerstein M.K. Carbohydrate-induced hypertriglyceridemia: modifying factors and implications for cardiovascular risk. Cur Opin Lipidol 2002, 13:33-40.
6. Schulze M.B., Manson J.E., Ludwig D.S., et al. Sugar-sweetened beverages, weight gain, and incidence of Type 2 diabetes in young and middle-aged women. J Am Med Assoc 2004, 292:927-934.
7. Mayes P.A. Intermediary metabolism of fructose. Am J Clin Nutr 1993, 58:754S-765S.
8. Nagai Y., Nishio Y., Nakamura T., Maegawa H., Kikkawa R., Kashiwagi A. Amelioration of high fructose-induced metabolic derangements by activation of PPARα. Am J Physiol Endocrinol Metabol 2002, 282:E1180-E1190.
9. Park J., Lemieux S., Lewis G.F., Kuksis A., Steiner G. Chronic exogenous insulin and chronic carbohydrate supplementation increase de novo VLDL triglyceride fatty acid production in rats. J Lipid Res 1997, 38:2529-2536.
10. Roglans N., Sanguino E., Peris C., et al. Atorvastatin treatment induced peroxisome proliferator-activated receptor a expression and decreased plasma nonesterified fatty acids and liver triglyceride in fructose-fed rats. J Pharmacol Exp Ther 2002, 302:232-239.
11. Roglans N., Vilà L., Alegret M., Sánchez R.M., Vázquez-Carrera M., Laguna J.C. Impairment of hepatic STAT-3 activation and reduction of PPARa activity in fructose-fed rats. Hepatology 2007, 45:778-788.
12. Vilà L., Roglans N., Alegret M., Sánchez R.M., Vázquez-Carrera M., Laguna J.C. Suppressor of cytokine signaling-3 (SOCS-3) and a deficit of serine/threonine (Ser/Thr) phosphoproteins involved in leptin transduction mediate the effect of fructose on rat liver lipid metabolism. Hepatology 2008, 48:1506-1516.
13. Helenius M., Hänninen M., Lehtinen S.K., Salminen A. Aging-induced up-regulation of nuclear binding activities of oxidative stress responsive NFkB transcription factor in mouse cardiac muscle. J Mol Cell Cardiol 1996, 28:487-498.
14. Bradford M.M. A rapid sensitive method for the quantitation of microgram quantities of protein utilizing the principles of protein-dye binding. Anal Biochem 1976, 72:248-254.
15. Qu S., Su D., Altomonte J., et al. PPARα mediates the hypolipidemic action of fibrates by antagonizing FoxO1. Am J Physiol Endocrinol Metabol 2007, 292:E421-E434.
16. Izquierdo-Pulido M.L., Hatae K., Haard N.F. Nucleotide catabolism and changes in texture indices during ice storage of cultured sturgeon, Acipenser transmontanus. J Food Biochem 1992, 16:173-192.
17. Lazarow P.B. Assay of peroxisomal β-oxidation of fatty acids. Meth Enzymol 1981, 72:315-319.
18. Planavila A., Laguna J.C., Vázquez-Carrera M. Nuclear factor kappa B activation leads to down regulation of fatty acid oxidation during cardiac hypertrophy. J Biol Chem 2005, 280:17464-17471.
19. Cabrero A., Alegret M., Sánchez R.M., Laguna J.C., Vázquez-Carrera M. Increased reactive oxygen species production down-regulates peroxisome proliferator-activated a pathway in C2C12 skeletal muscle cells. J Biol Chem 2002, 277:10100-10107.
20. Taguchi A., White M.F. Insulin-like signaling, nutrient homeostasis, and life span. Annu Rev Physiol 2008, 70:191-212.
21. Matsumoto M., Ogawa W., Akimoto K., et al. PKCl in liver mediates insulin-induced SREBP-1c expression and determines both hepatic lipid content and overall insulin sensitivity. J Clin Invest 2003, 112:935-944.
22. Yamashita H., Takenoshita M., Sakurai M., et al. A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver. Proc Natl Acad Sci U S A 2001, 98:9116-9121.
23. Kim S.Y., Kim H.I., Kim T.H., et al. SREBP-1c mediates the insulin dependent hepatic glucokinase expression. J Biol Chem 2004, 279:30823-30829.
24. Louet J.F., Hayhurst G., Gonzalez F.J., Girard J., Decaux J.F. The coactivator PGC-1 is involved in the regulation of the liver carnitine palmiotyltransferase I gene expression by cAMP in combination with HNF4α and cAMP-response element-binding protein (CREB). J Biol Chem 2002, 277:37991-38000.
25. Hardie D.G. AMP-activated protein kinase as a drug target. Annu Rev Pharmacol Toxicol 2007, 47:185-210.
26. Leclerc I., Lenznerd C., Gourdon L., Vaulont S., Kahn A., Viollet B. Hepatocyte nuclear factor-4α involved in type 1 maturity-onset diabetes of the young is a novel target of AMP-activated protein kinase. Diabetes 2001, 50:1515-1521.
27. Hong Y.H., Varanasi U.S., Yang W., Leff T. MP-activated protein kinase regulates HNF4α transcriptional activity by inhibiting dimer formation and decreasing protein stability. J Biol Chem 2003, 278:27495-27501.
28. Zhou G., Myers R., Li Y., et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001, 108:1174-1180.
29. Segal M.S., Gollub E., Johnson R.J. Is the fructose index more relevant with regards to cardiovascular disease than the glycemic index?. Eur J Nutr 2007, 46:406-4177.
30. Kim S.K., Novak R.F. The role of intracellular signaling in insulin-mediated regulation of drug metabolizing enzyme gene and protein expression. Pharmacol Ther 2007, 113:88-130.
31. Kin K.H., Song M.J., Yoo E.J., Choe S.S., Park S.D., Kim J.B. Regulatory role of glycogen synthase kinase 3 for transcriptional activity of ADD1/SREBP1c. J Biol Chem 2004, 279:51999-52006.
32. Zhang B.B., Zhou G., Li C. AMPK: An emerging drug target for diabetes and the metabolic syndrome. Cell Metabol 2009, 9:407-416.
33. Yu X., McCorkle S., Wang M., et al. Leptinomimetic effects of the AMP kinase activator AICAR in leptin-resistant rats: prevention of diabetes and ectopic lipid deposition. Diabetologia 2004, 47:2012-2021.
34. Andreelli F., Foretz M., Knauf C., et al. Liver adenosine monophosphate-activated kinase-a2 catalytic subunit is a key target for the control of hepatic glucose production by adiponectin and leptin but not insulin. Endocrinology 2006, 147:2432-2441.
35. Maenpaa P.H., Raivio K.O., Kekomaki M.P. Liver adenine nucleotides: fructose-induced depletion and its effect on protein synthesis. Science 1968, 161:1253-1254.
36. Uyeda K., Repa J.J. Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis. Cell Metabol 2006, 4:107-110.
37. Korieh A., Crouzoulon G. Dietary regulation of fructose metabolism in the intestine and in the liver of the rat. Duration of the effects of a high fructose diet after the return to the standard diet. Arch Int Physiol Biochim Biophys 1991, 99:455-460.
38. Tordoff M.G., Alleva A.M. Effect of drinking soda sweetened with aspartame or high-fructose corn syrup on food intake and body weight. Am J Clin Nutr 1990, 51:963-969.
39. Couchepin C., Lê K.A., Bortolotti M., et al. Markedly blunted metabolic effects of fructose in healthy young female subjects compared with male subjects. Diabetes Care 2008, 31:1254-1256.
40. Meyer K.A., Kushi L.H., Jacobs D.R., Slavin J., Sellers T.A., Folsom A.R. Carbohydrates, dietary fiber, and incident Type 2 diabetes in older women. Am J Clin Nutr 2000, 71:921-930.
41. Palmer J.R., Boggs D.A., Krishnan S., Hu F.B., Singer M., Rosenberg L. Sugar-sweetened beverages and incidence of Type 2 diabetes mellitus in African American women. Arch Intern Med 2008, 168:1487-1492.